The present study is designed to assess the natural history in a one year pre-phase of the
trial and evaluate therapeutic efficacy and side effects of deflazacort in LGMD2B/MM patients
in a placebo-controlled trial. Furthermore, long-term development of the disease under
naturalistic conditions will be documented in a 2-year follow-up after the end of the
double-blind treatment phase.